Description:
Herti is a HER2-targeted monoclonal antibody indicated for the treatment of HER2-positive breast and gastric cancers. It binds to the HER2 receptor, inhibiting downstream signaling pathways that drive cancer cell growth and survival.
Herti is used in both early-stage and metastatic settings, often as part of combination regimens. It is a cornerstone in personalized therapy for HER2-positive patients, improving survival outcomes and quality of life.
Share your experience with our medical product. Write a review!
17 Nov 2025
Early Detection Saves Lives: A Parent’s Guide to Preventive Care for Childhood Asthma
When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.
17 Nov 2025
The Role of Lifestyle Modifications in Chronic Disease Prevention
Chronic diseases-like type 2 diabetes, heart disease, hypertension, and certain cancers-are no longer just problems for “other people.”
29 Sep 2025
Gut Health and Immunity: Why a Healthy Digestive System is Your First Line of Defense
When most people think of the immune system, they imagine white blood cells, vaccines, or medicines that protect the body from infections.
29 Sep 2025
The Future of Pain Relief: From Traditional Balms to Next-Gen Transdermal Patches
Pain is one of the most common reasons people seek medical attention, whether it’s muscle pain after a long day, joint pain due to arthritis, or chronic conditions that affect daily living.
